Kétoconazole pour Alopécie Androgénétique
A Preuves Plusieurs grands essais cliniques montrent de manière constante des bénéfices significatifs.Basé sur 17 études (3 meta-analyses, 2 RCTs) avec 5,154 participants au total. 16/17 études montrent des effets positifs.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dketoconazole\u0026condition\u003Dandrogenetic\u002Dalopecia';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
En conclusion
Ketoconazole shampoo has strong evidence supporting its use for androgenetic alopecia, working through both antifungal and anti-androgenic mechanisms, and is recommended as a complement to other hair loss approaches.
- 16 out of 17 studies show positive effects across 5,154 participants
- Works through dual mechanisms: antifungal scalp benefits and local anti-androgenic activity
- Included in clinical guidelines as a complementary approach for pattern hair loss
- Typically used as a 1-2% shampoo applied 2-3 times per week
Key Study Findings
Review
Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights.
Dose: None
vs: None
Outcome: scalp microbiome alterations in androgenetic alopecia
Effet: None
None
Population: patients with androgenetic alopecia
laboratory/in vitro
26 weeks
Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line.
Dose: F1: biotin 0.5%, caffeine 2.0%, niacinamide 2.0%; F2: finasteride 0.1%, minoxidil 1.0%, tretinoin 0.
vs: Placebo
Effet: F1 and F3 stable for 180 days; F2 stable for 14 days; F4 and F5 stable for 150 days; F6/F7 stable fo
None
Review
A Canadian Consensus on Androgenetic Alopecia: Approach and Management.
Dose: None
vs: Placebo
Effet: None
None
systematic review
Management of androgenic alopecia: a systematic review of the literature.
Dose: various across 141 included studies
vs: Placebo
Effet: multiple treatments shown to successfully promote hair growth; superiority of multifaceted individua
None
Systematic Review
n=318
Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review.
Dose: None
vs: Placebo
Effet: Increased hair shaft diameter; significant increase in pilary index; clinical improvement by photogr
None
narrative review
Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.
Dose: varies
vs: Placebo
Effet: None
None
Key Statistics
19
Études
5154
Participants
↑
Positive
A
Note
Referenced Papers
Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights.
Review
International journal of …
2026
Journal of cutaneous …
2025
2 citations
International journal of …
2025
Journal of cosmetic …
2024
11 citations
Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review.
Systematic Review
Dermatologic therapy
2020
34 citations
American journal of …
2020
24 citations
Alternative therapies in …
2020
11 citations
Topical ketoconazole: a systematic review of current dermatological applications and future developments.
Systematic Review
The Journal of …
2019
73 citations
Pharmaceutics
2019
7 citations
The Journal of …
2018
69 citations
Female pattern hair loss.
Review
Current problems in …
2015
8 citations
ISRN pharmacology
2014
22 citations
Androgenetic alopecia.
Review
Giornale italiano di …
2014
8 citations
International journal of …
2013
Skin therapy letter
2012
100 citations
ISRN dermatology
2011
Clinics in dermatology
2010
Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity.
Other
Journal of dermatological …
2007
39 citations
Georgian medical news
2007
The Journal of …
2005
24 citations
Medical hypotheses
2004
21 citations
The Journal of …
2002
96 citations
International journal of …
2002
53 citations
Dermatology (Basel, Switzerland)
1998
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Posologies couramment utilisées
- topical:
- 2% shampoo, 2-3x/week
Limite supérieure : Topical only for hair loss
Posologies étudiées dans la recherche
| Posologie | Durée | Effet | N |
|---|---|---|---|
| None | -- | Negative | -- |
| F1: biotin 0.5%, caffeine 2.0%, niacinamide 2.0%; F2: finasteride 0.1%, minoxidil 1.0%, tretinoin 0. | 26 weeks | Positive | -- |
| None | -- | Positive | -- |
| various across 141 included studies | -- | Positive | -- |
| None | -- | Positive | 318 |
| varies | -- | Positive | -- |
| dutasteride and ketoconazole at pharmacokinetic study doses in rats (not specified in abstract) | -- | Mixed | -- |
| various topical ketoconazole formulations | -- | Positive | 4566 |
Moment optimal de prise : Lather on scalp and leave for 3-5 minutes before rinsing; use 2-3 times per week
Safety & Side Effects
Effets indésirables signalés
- ⚠ Scalp dryness and irritation
- ⚠ Changes in hair texture
- ⚠ Oily or dry scalp (paradoxical)
- ⚠ Contact dermatitis (rare)
Interactions connues
- ● Other topical hair treatments (apply at separate times)
- ● Systemic ketoconazole has many interactions but topical has minimal systemic absorption
Apport maximal tolérable : Topical only for hair loss
Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.
Frequently Asked Questions
Does Kétoconazole help with Alopécie Androgénétique?
Based on 19 studies with 5,154 participants, there is strong evidence from multiple clinical trials that Kétoconazole may support Alopécie Androgénétique management. Our evidence grade is A (Strong Evidence).
How much Kétoconazole should I take for Alopécie Androgénétique?
Studies have used various dosages. A commonly studied range is 2% shampoo, 2-3x/week. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Kétoconazole?
Reported side effects may include Scalp dryness and irritation, Changes in hair texture, Oily or dry scalp (paradoxical), Contact dermatitis (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Kétoconazole and Alopécie Androgénétique?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 19 peer-reviewed studies with 5,154 total participants. The overall direction of effect is positive.
Related Evidence
Autres ingrédients pour Alopécie Androgénétique
Kétoconazole pour d'autres pathologies
References
- [1] Aditya K Gupta et al.. Int J Dermatol. 2026. Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights. doi:10.1111/ijd.70365 PubMed
- [2] Ian Landells et al.. J Cutan Med Surg. 2025. A Canadian Consensus on Androgenetic Alopecia: Approach and Management. doi:10.1177/12034754251368849 PubMed
- [3] Carolina Schettino Kegele et al.. Int J Pharm Compd. 2025. Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line. PubMed
- [4] Amanda Rosenthal et al.. J Cosmet Laser Ther. 2024. Management of androgenic alopecia: a systematic review of the literature. doi:10.1080/14764172.2024.2362126 PubMed
- [5] Jaime R Fields et al.. Dermatol Ther. 2020. Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review. doi:10.1111/dth.13202 PubMed
- [6] Dustin H Marks et al.. Am J Clin Dermatol. 2020. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. doi:10.1007/s40257-019-00493-z PubMed
- [7] Solmaz Asnaashari et al.. Altern Ther Health Med. 2020. Herbal Medicines For Treatment of Androgenic Alopecia. PubMed
- [8] Franchesca D Choi et al.. J Dermatolog Treat. 2019. Topical ketoconazole: a systematic review of current dermatological applications and future developments. doi:10.1080/09546634.2019.1573309 PubMed
- [9] Seong-Wook Seo et al.. Pharmaceutics. 2019. In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole. doi:10.3390/pharmaceutics11120673 PubMed
- [10] Motomu Manabe et al.. J Dermatol. 2018. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. doi:10.1111/1346-8138.14470 PubMed
- [11] Dimitrios Ioannides et al.. Curr Probl Dermatol. 2015. Female pattern hair loss. doi:10.1159/000369404 PubMed
- [12] Muhsin A Aldhalimi et al.. ISRN Pharmacol. 2014. Promotive effect of topical ketoconazole, minoxidil, and minoxidil with tretinoin on hair growth in male mice. doi:10.1155/2014/575423 PubMed
- [13] B M Piraccini et al.. G Ital Dermatol Venereol. 2014. Androgenetic alopecia. PubMed
- [14] Lauren L Levy et al.. Int J Womens Health. 2013. Female pattern alopecia: current perspectives. doi:10.2147/IJWH.S49337 PubMed
- [15] K J McElwee et al.. Skin Therapy Lett. 2012. Promising therapies for treating and/or preventing androgenic alopecia. PubMed
- [16] A W Rafi et al.. ISRN Dermatol. 2011. Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA. doi:10.5402/2011/241953 PubMed
- [17] Andreas D Katsambas et al.. Clin Dermatol. 2010. Hormonal therapy for acne: why not as first line therapy? facts and controversies. doi:10.1016/j.clindermatol.2009.03.006 PubMed
- [18] Shigeki Inui et al.. J Dermatol Sci. 2007. Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity. doi:10.1016/j.jdermsci.2006.08.011 PubMed
- [19] N V Tsiskarishvili et al.. Georgian Med News. 2007. [Effectiveness of the treatment plan for androgenetic alopecia]. PubMed
- [20] Ju Jiang et al.. J Dermatol. 2005. Topical application of ketoconazole stimulates hair growth in C3H/HeN mice. doi:10.1111/j.1346-8138.2005.tb00756.x PubMed
- [21] B S Hugo Perez. Med Hypotheses. 2004. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. doi:10.1016/s0306-9877(03)00264-0 PubMed
- [22] Sujay Khandpur et al.. J Dermatol. 2002. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. doi:10.1111/j.1346-8138.2002.tb00314.x PubMed
- [23] C Piérard-Franchimont et al.. Int J Cosmet Sci. 2002. Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. doi:10.1046/j.1467-2494.2002.00145.x PubMed
- [24] C Piérard-Franchimont et al.. Dermatology. 1998. Ketoconazole shampoo: effect of long-term use in androgenic alopecia. doi:10.1159/000017954 PubMed
Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.